These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 399460)

  • 21. Some selected studies on hepatic microsomal drug-metabolizing enzymes--environment interactions.
    Fouts JR
    Drug Metab Dispos; 1973; 1(1):380-5. PubMed ID: 4149408
    [No Abstract]   [Full Text] [Related]  

  • 22. Considerations of toxicologic interactions in developing new chemicals.
    Wilkinson CF; Murray M
    Drug Metab Rev; 1984; 15(5-6):897-917. PubMed ID: 6396059
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic capabilities of the human fetus: drug biotransformation.
    Juchau MR
    Addict Dis; 1975; 2(1-2):37-43. PubMed ID: 1163372
    [No Abstract]   [Full Text] [Related]  

  • 24. [Metabolic drug interactions of trapidil (Rocornal)].
    Borchert HH; Szołomicka-Orfinger I; Pfeifer S
    Pharmazie; 1978 Oct; 33(10):663-8. PubMed ID: 724748
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cytochrome P-450: the effect of drugs and poisons].
    Chekman IS; Grinevich AI
    Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of drug-metabolizing activities in the livers of carcinogen-sensitive parent rats and carcinogen-resistant descendants.
    Yoshimoto F; Masuda S; Higashi T; Nishii T; Takamisawa I; Tateishi N; Sakamoto Y
    Cancer Res; 1985 Dec; 45(12 Pt 1):6155-9. PubMed ID: 3933822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 enzyme activities in the Australian brushtail possum trichosurus vulpesula: a comparison with the rat, rabbit, sheep and chicken.
    Olkowski A; Gooneratne R; Eason C
    Vet Hum Toxicol; 1998 Apr; 40(2):70-6. PubMed ID: 9554057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM; Bammler TK; Hayes JD; Eaton DL
    Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug catabolism and its significance for pharmacotherapy].
    Kolenda KD
    Med Klin; 1980 Mar; 75(7):240-50. PubMed ID: 6771507
    [No Abstract]   [Full Text] [Related]  

  • 30. Microsomal metabolism of dimethylnitrosamine and the cytochrome P-450 dependency of its activation to a mutagen.
    Czygan P; Greim H; Garro AJ; Hutterer F; Schaffner F; Popper H; Rosenthal O; Cooper DY
    Cancer Res; 1973 Nov; 33(11):2983-6. PubMed ID: 4201248
    [No Abstract]   [Full Text] [Related]  

  • 31. Strategies for determining the mechanisms of toxicity.
    Gillette J; Weisburger EK; Kraybill H; Kelsey M
    J Toxicol Clin Toxicol; 1985; 23(1):1-78. PubMed ID: 3903179
    [No Abstract]   [Full Text] [Related]  

  • 32. Computational chemistry in biotransformational and toxicological research. Mechanisms of oxidation by and active site structure of cytochromes P-450.
    Koymans LM
    Pharm World Sci; 1993 Apr; 15(2):86-8. PubMed ID: 8490590
    [No Abstract]   [Full Text] [Related]  

  • 33. How safe are pesticides?
    Geissbühler H
    Experientia; 1982 Aug; 38(8):890-5. PubMed ID: 7128725
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental testing of a rodenticidal preparation, Pyriminyl (Vacor), in small animals].
    Konrád J; Husák S; Svoboda M; Mouka M; Cupák M
    Vet Med (Praha); 1980 Aug; 25(8):501-9. PubMed ID: 6775411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the nature of non-genotoxic carcinogens. A unified theory including NGCs, co-carcinogens and promoters.
    Paolini M; Biagi GL; Bauer C; Cantelli-Forti G
    Mutat Res; 1992 Apr; 281(4):245-6. PubMed ID: 1373217
    [No Abstract]   [Full Text] [Related]  

  • 36. Biologically active intermediates generated by the reduced glutathione conjugation pathway. Toxicological implications.
    Igwe OJ
    Biochem Pharmacol; 1986 Sep; 35(18):2987-94. PubMed ID: 2428375
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxicological Evaluation of Chemical Interactions. Proceedings of the IVth European ISSX meeting. Bologna, Italy, July 3-6, 1992.
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):1-167. PubMed ID: 7698068
    [No Abstract]   [Full Text] [Related]  

  • 38. The pros and cons of publishing genetic toxicology studies in which the identities of the compounds are withheld.
    Phillips DH
    Mutagenesis; 2004 Jan; 19(1):1. PubMed ID: 14681307
    [No Abstract]   [Full Text] [Related]  

  • 39. How is an optimum environment defined?
    Potter VR
    Environ Res; 1969 Oct; 2(5):476-87. PubMed ID: 5381591
    [No Abstract]   [Full Text] [Related]  

  • 40. N-3-pyridylmethyl-N'-p-nitrophenylurea ocular toxicity in man and an animal model.
    Mindel JS
    Trans Am Ophthalmol Soc; 1986; 84():389-428. PubMed ID: 3590476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.